Get started
Author

Rannissa Puspita Jayanti

Institution: Inje University
Observed institution: Inje University
ORCID: 0000-0002-9101-1965
Observed ORCID: 0000-0002-9101-1965
OpenAlex ID: A5068280842
Advancing personalized medicine for tuberculosis through the application of immune profiling
2023 · Vo Thuy Anh Thu, Ly Da Dat, et al. · Frontiers in Cellular and Infection Microbiology · 25
PDF
Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes
2023 · Nguyen Thi Hai Yen, Nguyen Ky Anh, et al. · Biochimie · 24
Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring
2023 · Nguyen Ky Anh, Nguyen Ky Phat, et al. · Biomedicine & Pharmacotherapy · 20
Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis
2022 · Soedarsono Soedarsono, Rannissa Puspita Jayanti, et al. · International Journal of Infectious Diseases · 20
PDF
Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management
2022 · Rannissa Puspita Jayanti, Nguyen Phuoc Long, et al. · Pharmaceutics · 17
PDF
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure
2023 · Pham Quang Hoa, Hyun Kuk Kim, et al. · International Journal of Antimicrobial Agents · 11
Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance
2023 · Ryunha Kim, Rannissa Puspita Jayanti, et al. · Frontiers in Pharmacology · 10
PDF
Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort
2023 · Tran Minh Hung, Rannissa Puspita Jayanti, et al. · International Journal of Antimicrobial Agents · 7
Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis
2023 · Soedarsono Soedarsono, Rannissa Puspita Jayanti, et al. · Tuberculosis · 6
Web-based automated therapeutic drug monitoring application for precision medicine in tuberculosis management
2025 · Young-Kyung Choi, Rannissa Puspita Jayanti, et al. · Translational and Clinical Pharmacology · 2
PDF
Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure
2026 · Rannissa Puspita Jayanti, Yong-Soon Cho, et al. · PLoS ONE · 1
PDF
Population pharmacokinetics of levofloxacin in drug-susceptible and drug-resistant tuberculosis patients: Optimal dose suggestion based on renal function
2025 · Yong-Soon Cho, Rannissa Puspita Jayanti, et al. · Tuberculosis · 1
Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure
2026 · Rannissa Puspita Jayanti, Yong-Soon Cho, et al. · PLoS ONE
Works count: 13
Citation count: 144
H-index: 7
I10-index: 7
Year
Topic
Type